DK139593D0 - Compounds - Google Patents

Compounds

Info

Publication number
DK139593D0
DK139593D0 DK931395A DK139593A DK139593D0 DK 139593 D0 DK139593 D0 DK 139593D0 DK 931395 A DK931395 A DK 931395A DK 139593 A DK139593 A DK 139593A DK 139593 D0 DK139593 D0 DK 139593D0
Authority
DK
Denmark
Prior art keywords
alkyl
hydrogen
group
alkenyl
formula
Prior art date
Application number
DK931395A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to DK931395A priority Critical patent/DK139593D0/da
Publication of DK139593D0 publication Critical patent/DK139593D0/da
Priority to ZA949918A priority patent/ZA949918B/xx
Priority to DK95903771T priority patent/DK0734384T3/da
Priority to PL94315027A priority patent/PL181253B1/pl
Priority to DE69425510T priority patent/DE69425510T2/de
Priority to IL11198994A priority patent/IL111989A/xx
Priority to PT95903771T priority patent/PT734384E/pt
Priority to PCT/DK1994/000470 priority patent/WO1995016684A1/en
Priority to AT95903771T priority patent/ATE195313T1/de
Priority to JP7516476A priority patent/JPH09506595A/ja
Priority to SI9430338T priority patent/SI0734384T1/xx
Priority to SK758-96A priority patent/SK283451B6/sk
Priority to US08/666,380 priority patent/US5789404A/en
Priority to CA002179179A priority patent/CA2179179A1/en
Priority to NZ277483A priority patent/NZ277483A/en
Priority to RU96115139/04A priority patent/RU2139287C1/ru
Priority to CN94194964A priority patent/CN1080261C/zh
Priority to CZ961727A priority patent/CZ285028B6/cs
Priority to ES95903771T priority patent/ES2149959T3/es
Priority to HU9601640A priority patent/HU223318B1/hu
Priority to EP99106459A priority patent/EP0939077A3/en
Priority to AU12721/95A priority patent/AU682915B2/en
Priority to HK98115080.2A priority patent/HK1013815B/en
Priority to EP95903771A priority patent/EP0734384B1/en
Priority to KR1019960703199A priority patent/KR100363484B1/ko
Priority to NO962505A priority patent/NO306671B1/no
Priority to FI962496A priority patent/FI962496A7/fi
Priority to GR20000402432T priority patent/GR3034744T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK931395A 1993-12-16 1993-12-16 Compounds DK139593D0 (da)

Priority Applications (28)

Application Number Priority Date Filing Date Title
DK931395A DK139593D0 (da) 1993-12-16 1993-12-16 Compounds
ZA949918A ZA949918B (en) 1993-12-16 1994-12-13 3-substituted 1-arylindole compounds
KR1019960703199A KR100363484B1 (ko) 1993-12-16 1994-12-15 3-치환1-아릴인돌화합물
US08/666,380 US5789404A (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds
RU96115139/04A RU2139287C1 (ru) 1993-12-16 1994-12-15 Соединения 3-замещенного 1-арилиндола и фармацевтическая композиция на их основе
DE69425510T DE69425510T2 (de) 1993-12-16 1994-12-15 3-substituierte 1-arylindolverbindungen
IL11198994A IL111989A (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds and pharmaceutical compositions containing them
PT95903771T PT734384E (pt) 1993-12-16 1994-12-15 Compostos de 1-arilindole 3substituidos
PCT/DK1994/000470 WO1995016684A1 (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds
AT95903771T ATE195313T1 (de) 1993-12-16 1994-12-15 3-substituierte 1-arylindolverbindungen
JP7516476A JPH09506595A (ja) 1993-12-16 1994-12-15 ３−置換された１−アリールインドール化合物
SI9430338T SI0734384T1 (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds
SK758-96A SK283451B6 (sk) 1993-12-16 1994-12-15 3-Substituované 1-arylindolové zlúčeniny, farmaceutické prostriedky s ich obsahom a ich použitie
DK95903771T DK0734384T3 (da) 1993-12-16 1994-12-15 3-substituerede 1-arylindolforbindelser
CA002179179A CA2179179A1 (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds
NZ277483A NZ277483A (en) 1993-12-16 1994-12-15 1-arylindole derivatives and medicaments
PL94315027A PL181253B1 (pl) 1993-12-16 1994-12-15 Nowe 3-podstawione związki 1-aryloindolowe oraz zawierające je kompozycje farmaceutyczne
CN94194964A CN1080261C (zh) 1993-12-16 1994-12-15 3－取代的1－芳基吲哚化合物
CZ961727A CZ285028B6 (cs) 1993-12-16 1994-12-15 3-substituované 1-arylindolové deriváty, jejich použití a farmaceutické prostředky s jejich obsahem
ES95903771T ES2149959T3 (es) 1993-12-16 1994-12-15 Compuestos de 1-arilindol sustituidos en la posicion 3.
HU9601640A HU223318B1 (hu) 1993-12-16 1994-12-15 3-Helyzetben szubsztituált-1-aril-indol-származékok, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
EP99106459A EP0939077A3 (en) 1993-12-16 1994-12-15 3-Substituted 1-arylindole compounds as 5-HT2 antagonists
AU12721/95A AU682915B2 (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds
HK98115080.2A HK1013815B (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds
EP95903771A EP0734384B1 (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds
NO962505A NO306671B1 (no) 1993-12-16 1996-06-13 3-substituerte 1-arylindolforbindelser
FI962496A FI962496A7 (fi) 1993-12-16 1996-06-14 3-substituoidut 1-aryyli-indoliyhdisteet
GR20000402432T GR3034744T3 (en) 1993-12-16 2000-11-02 3-substituted 1-arylindole compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK931395A DK139593D0 (da) 1993-12-16 1993-12-16 Compounds

Publications (1)

Publication Number Publication Date
DK139593D0 true DK139593D0 (da) 1993-12-16

Family

ID=8104386

Family Applications (2)

Application Number Title Priority Date Filing Date
DK931395A DK139593D0 (da) 1993-12-16 1993-12-16 Compounds
DK95903771T DK0734384T3 (da) 1993-12-16 1994-12-15 3-substituerede 1-arylindolforbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK95903771T DK0734384T3 (da) 1993-12-16 1994-12-15 3-substituerede 1-arylindolforbindelser

Country Status (24)

Country Link
US (1) US5789404A (da)
EP (2) EP0939077A3 (da)
JP (1) JPH09506595A (da)
KR (1) KR100363484B1 (da)
CN (1) CN1080261C (da)
AT (1) ATE195313T1 (da)
AU (1) AU682915B2 (da)
CA (1) CA2179179A1 (da)
CZ (1) CZ285028B6 (da)
DE (1) DE69425510T2 (da)
DK (2) DK139593D0 (da)
ES (1) ES2149959T3 (da)
FI (1) FI962496A7 (da)
GR (1) GR3034744T3 (da)
HU (1) HU223318B1 (da)
IL (1) IL111989A (da)
NO (1) NO306671B1 (da)
NZ (1) NZ277483A (da)
PL (1) PL181253B1 (da)
PT (1) PT734384E (da)
RU (1) RU2139287C1 (da)
SK (1) SK283451B6 (da)
WO (1) WO1995016684A1 (da)
ZA (1) ZA949918B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2195850A1 (en) * 1994-08-03 1996-02-15 Asta Medica Aktiengesellschaft Substituted indoles
MY125942A (en) * 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
RU2337906C2 (ru) * 2001-12-03 2008-11-10 Уайт Ингибиторы цитозольной фосфолипазы а2
SI1517909T1 (sl) * 2002-06-21 2007-06-30 Suven Life Sciences Ltd Novi tetraciklični arilkarbonil indoli, ki imajo afiniteto za serotoninski receptor, uporabni kot terapevtska sredstva, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
BR0312175A (pt) * 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
DE602005020280D1 (de) * 2004-06-01 2010-05-12 Hoffmann La Roche 3-amino-1-arylpropyl-indole als monoamin-wiederaufnahmehemmer
US8604031B2 (en) 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1220628A (en) * 1968-07-20 1971-01-27 Pfizer Ltd N-phenyl indole derivatives and pharmaceutical compositions thereof
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
DE1911893A1 (de) * 1969-03-08 1970-09-24 Thiemann Gmbh Chem Pharm Fabri Verfahren zur Herstellung von N-(Halogen-aryl)-2-methyl-5-alkoxy-indol-3-essigsaeuren
SU373941A3 (da) * 1970-01-21 1973-03-12
BE795457A (fr) * 1972-02-16 1973-08-16 Clin Midy Amines indoliques, leur preparation et leur application en therapeutiques
FR2242091A1 (en) * 1973-09-04 1975-03-28 Delalande Sa 1-Phenyl-2-methyl-3-aminomethyl-5-methoxy indole derivs - with e.g. analgesic, antidepressive and anti-arrhythmic props
US4558048A (en) * 1984-04-06 1985-12-10 Pfizer Inc. Method of treating diarrhoea using indole compounds
DE3430284A1 (de) * 1984-08-17 1986-02-27 Troponwerke GmbH & Co KG, 5000 Köln Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
DK152090D0 (da) * 1990-06-22 1990-06-22 Lundbaek A S H Piperidylsubstituerede indolderivater
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
DK36391D0 (da) * 1991-03-01 1991-03-01 Lundbeck & Co As H Anvendelse af piperidylsubstituerede indolderivater til behandling af stofmisbrug
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2705346B1 (fr) * 1993-05-18 1995-08-11 Union Pharma Scient Appl Nouveaux dérivés de pipéridinyl thio indole, leurs procédés de préparation, compositions pharmaceutiques les contenant, utiles notamment comme antalgiques .
US5504101A (en) * 1994-05-06 1996-04-02 Allelix Biopharmaceuticals, Inc. 5-HT-1D receptor ligands

Also Published As

Publication number Publication date
IL111989A0 (en) 1995-03-15
NO962505D0 (no) 1996-06-13
DK0734384T3 (da) 2001-01-02
EP0939077A2 (en) 1999-09-01
EP0939077A3 (en) 2003-11-19
PL181253B1 (pl) 2001-06-29
RU2139287C1 (ru) 1999-10-10
CZ172796A3 (en) 1996-11-13
PL315027A1 (en) 1996-09-30
IL111989A (en) 2000-10-31
DE69425510D1 (de) 2000-09-14
ZA949918B (en) 1995-08-23
NO306671B1 (no) 1999-12-06
CN1142824A (zh) 1997-02-12
US5789404A (en) 1998-08-04
DE69425510T2 (de) 2001-04-19
NZ277483A (en) 1998-05-27
AU1272195A (en) 1995-07-03
PT734384E (pt) 2000-12-29
SK75896A3 (en) 1996-11-06
KR100363484B1 (ko) 2003-02-05
HK1013815A1 (en) 1999-09-10
CZ285028B6 (cs) 1999-05-12
HU223318B1 (hu) 2004-05-28
ATE195313T1 (de) 2000-08-15
JPH09506595A (ja) 1997-06-30
NO962505L (no) 1996-08-12
WO1995016684A1 (en) 1995-06-22
GR3034744T3 (en) 2001-02-28
FI962496A0 (fi) 1996-06-14
AU682915B2 (en) 1997-10-23
HU9601640D0 (en) 1996-08-28
ES2149959T3 (es) 2000-11-16
CN1080261C (zh) 2002-03-06
FI962496A7 (fi) 1996-06-14
EP0734384B1 (en) 2000-08-09
SK283451B6 (sk) 2003-08-05
HUT76276A (en) 1997-07-28
KR960706492A (ko) 1996-12-09
CA2179179A1 (en) 1995-06-22
EP0734384A1 (en) 1996-10-02

Similar Documents

Publication Publication Date Title
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
DE69630214D1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
FI943247A0 (fi) Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina
DE3473143D1 (de) Anticonvulsant sulfamate derivatives
NO1998008I1 (no) Naratriptan
FI893751A0 (fi) Kemiska foereningar.
ATE41930T1 (de) Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung.
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
SE8505887L (sv) Indoler
DE69202120D1 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
ATE195313T1 (de) 3-substituierte 1-arylindolverbindungen
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
ATE83234T1 (de) Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung.
SE8303913D0 (sv) Heterocykliska foreningar
DE69616357D1 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
FI860074A0 (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
DK52383A (da) Fremgangsmaade til fremstilling af carbacyklinderivater
FI915025A0 (fi) 8-azabicyklo(3,2,1) oktylalkyltiazolidinoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE94548T1 (de) Prostaglandin-vorlaeufer und ihre herstellung.
HUT45059A (en) Process for producing abeoergoline derivatives
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
ATE7694T1 (de) Derivate von 2-methyl-5-thiazolmethylamin und carboxamid.
ATE19881T1 (de) Tropyl- und pseudotropylalkylbenzoate und ihre verwendung in der behandlung von migraene.

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment